Compare FMST & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FMST | EVGN |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | Canada | Israel |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Agricultural Chemicals |
| Sector | Basic Materials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2M | 9.9M |
| IPO Year | N/A | N/A |
| Metric | FMST | EVGN |
|---|---|---|
| Price | $2.29 | $1.09 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.50 |
| AVG Volume (30 Days) | ★ 224.4K | 58.9K |
| Earning Date | 02-21-2026 | 11-20-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $8,016,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 7.19 |
| 52 Week Low | $0.55 | $0.93 |
| 52 Week High | $5.74 | $2.42 |
| Indicator | FMST | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.26 | 49.77 |
| Support Level | $2.19 | $0.93 |
| Resistance Level | $2.50 | $1.21 |
| Average True Range (ATR) | 0.14 | 0.06 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 37.50 | 55.36 |
Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.